CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study.

CONCLUSIONS: CSF CYFRA 21-1 may have utility as a therapeutic monitoring biomarker to design personalized therapeutic strategies in LMC patients undergoing VLP chemotherapy. PMID: 32176621 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32176621?dopt=Abstract

Source: Cancer Biomarkers - March 18, 2020 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research